Identified prognostic subsets in metastatic rhabdomyosarcoma to guide experimental treatment candidate selection.
Answers are grounded in this paper and cite their sources.
Refines prognostic stratification in metastatic rhabdomyosarcoma; extends selection of candidates for experimental therapies in future trials.
This analysis identified subsets of patients with metastatic rhabdomyosarcoma with different outcomes to current therapy and offers a strategy to define patient candidates for experimental approaches to treatment.
No takes yet. Share an insight, caveat, or question.
Oberlin et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: